A detailed history of Integrated Investment Consultants, LLC transactions in Repligen Corp stock. As of the latest transaction made, Integrated Investment Consultants, LLC holds 2,226 shares of RGEN stock, worth $311,484. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,226
Previous 2,226 -0.0%
Holding current value
$311,484
Previous $409,000 31.54%
% of portfolio
0.08%
Previous 0.12%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 23, 2024

SELL
$114.17 - $185.35 $1,027 - $1,668
-9 Reduced 0.4%
2,226 $400,000
Q3 2023

Oct 17, 2023

BUY
$138.78 - $176.51 $693 - $882
5 Added 0.22%
2,235 $355,000
Q2 2023

Jul 18, 2023

BUY
$138.42 - $180.31 $308,676 - $402,091
2,230 New
2,230 $315,000
Q1 2023

Jul 18, 2023

BUY
$154.26 - $198.1 $102,891 - $132,132
667 Added 29.91%
2,897 $487,000
Q1 2018

Apr 12, 2018

BUY
$30.92 - $37.27 $9,276 - $11,181
300 New
300 $11,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.76B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Integrated Investment Consultants, LLC Portfolio

Follow Integrated Investment Consultants, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Investment Consultants, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Investment Consultants, LLC with notifications on news.